Imaging PD-L1 Expression with ImmunoPET
Charles Truillet(Université Paris-Sud), Hsueh Ling Janice Oh(Agency for Science, Technology and Research), Siok Ping Yeo(Agency for Science, Technology and Research), Chia‐Yin Lee(Agency for Science, Technology and Research), Loc T. Huynh(University of California, San Francisco), Junnian Wei(University of California, San Francisco), Matthew F.L. Parker(University of California, San Francisco), Collin M. Blakely, Natalia Sevillano, Yung-Hua Wang(University of California, San Francisco), Yuqin Shen(University of California, San Francisco), Victor Olivas, Khaled M. Jami(University of California, San Francisco), Anna Moroz(Skolkovo Institute of Science and Technology), Benoit Jégo(Université Paris-Sud), Emilie Jaumain(Université Paris-Sud), Lawrence Fong, Charles S. Craik, Albert J. Chang, Trever G. Bivona, Cheng‐I Wang(Université Paris-Sud), Michael J. Evans(University of California, San Francisco)
Cited by 129Open Access
Abstract
Zr-C4 could detect acute changes in tumor expression of PD-L1 due to standard of care chemotherapies. In summary, we present evidence that low levels of PD-L1 in clinically relevant cancer models can be imaged with immunoPET using a novel recombinant human antibody.
Related Papers
No related papers found
Powered by citation graph analysis